Stocks-IMGN-ImmunoGen Inc

IMGN ImmunoGen Inc

31.23 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

ImmunoGen Inc price

0% Past Week
Market Cap
8.72B
Day’s Range
31.17
-
31.19
52W Range
3.60
-
31.19
Volume (3M)
8.92M
Price-Earnings Ratio
-104.24
Revenue
287.61M

ImmunoGen Inc Latest News

View All
Pinned Post
Cancer Treatment Stocks
Novartis to acquire cancer-focused MorphoSys for $2.9 billion. 💊 Drugmaker $NVS (Novartis ADR) said it will acquire $MOR.DE (MorphoSys), a developer of cancer treatments, for €2.7 billion, adding a promising rare bone-marrow cancer treatment candidate to its portfolio. German biotech firm's shares... Show More
Like CommentShare
Show more comments2 of 3
null
.
Top Discussions

IMGN Upcoming events

29
FEB
Earnings Report
Q1 2024
Before Market Open

Analyst Forecast

Consensus
Hold
Price Target
31.09

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
39
Very Low
Industry 
Avg. 43 
30
Environment
42
Social
39
Governance

People Also Bought